{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:52:59Z","timestamp":1793933579060,"version":"4.8.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.mayocp.2012.01.007","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T03:29:40Z","timestamp":1331004580000},"page":"290-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["Current Concepts in Laboratory Testing to Guide Antimicrobial Therapy"],"prefix":"10.1016","volume":"87","author":[{"given":"Stephen G.","family":"Jenkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey N.","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2012.01.007_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the Infectious Disease Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2012.01.007_bib2","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2012"},{"key":"10.1016\/j.mayocp.2012.01.007_bib3","volume":"Vol. ISO\/DIS 20776-1","year":"2006"},{"key":"10.1016\/j.mayocp.2012.01.007_bib4","series-title":"Performance Standards for Antimicrobial Disk Susceptibility Tests","year":"2012"},{"key":"10.1016\/j.mayocp.2012.01.007_bib5","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2012"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/jcm.18.3.645-651.1983","article-title":"Influence of inoculum growth phase on microdilution susceptibility tests","volume":"18","author":"Barry","year":"1983","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/infdis\/130.6.588","article-title":"Susceptibility tests of anaerobic bacteria: statistical and clinical considerations","volume":"130","author":"Metzler","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mayocp.2012.01.007_bib8","series-title":"Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters","year":"2008"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"Antibiotic susceptibility testing by a standardized single disk method","volume":"45","author":"Bauer","year":"1966","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/jcm.29.3.533-538.1991","article-title":"Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria","volume":"29","author":"Baker","year":"1991","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.01.007_bib11","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1128\/jcm.30.12.3243-3248.1992","article-title":"Accuracy of the E Test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents","volume":"30","author":"Huang","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.5858\/2006-130-767-PAOAAA","article-title":"Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003)","volume":"130","author":"Pfaller","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.mayocp.2012.01.007_bib13","series-title":"Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria","year":"2010"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/sur.2007.096","article-title":"Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis","volume":"10","author":"Goldstein","year":"2009","journal-title":"Surg Infect"},{"issue":"7","key":"10.1016\/j.mayocp.2012.01.007_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/512197","article-title":"Reemergence of anaerobic bacteremia","volume":"44","author":"Lassmann","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2012.01.007_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10096-008-0487-5","article-title":"Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteremia","volume":"27","author":"Robert","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/516355","article-title":"Clinical significance and outcome of anaerobic bacteremia","volume":"26","author":"Salonen","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10096-004-1111-y","article-title":"Risk factors for mortality in patients with anaerobic bacteremia","volume":"23","author":"Wilson","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2012.01.007_bib19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1469-0691.2005.01214.x","article-title":"Incidence and clinical significance of anaerobic bacteremia in cancer patients: a 6-year retrospective study","volume":"11","author":"Zahar","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.mayocp.2012.01.007_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0196-4399(90)90014-3","article-title":"Son of anaerobic susceptibility testing \u2013 revisited","volume":"12","author":"Baron","year":"1990","journal-title":"Clin Microbiol Newsletter"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2012.01.007_bib21","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/516241","article-title":"Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis","volume":"25","author":"Dougherty","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2012.01.007_bib22","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1086\/516233","article-title":"Perspective on susceptibility testing of anaerobic bacteria","volume":"25","author":"Finegold","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"suppl 4","key":"10.1016\/j.mayocp.2012.01.007_bib23","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1093\/clinids\/16.Supplement_4.S446","article-title":"Clinical relevance of susceptibility testing of anaerobic bacteria","volume":"16","author":"Rosenblatt","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2012.01.007_bib24","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1086\/516244","article-title":"In defense of routine antimicrobial susceptibility testing of operative site flora in patients with peritonitis","volume":"25","author":"Wilson","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jac\/dkg320","article-title":"Emergence of fluoroquinolone resistance among Bacteroides species","volume":"52","author":"Golan","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib26","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/313805","article-title":"Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial","volume":"30","author":"Nguyen","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"suppl 4","key":"10.1016\/j.mayocp.2012.01.007_bib27","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1093\/clinids\/16.Supplement_4.S357","article-title":"Variation in the susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals","volume":"16","author":"Hecht","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2012.01.007_bib28","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/AAC.01435-06","article-title":"National survey on the susceptibility of Bacteroides fragilis group: report and analysis of tends in the United States from 1997 to 2004","volume":"51","author":"Snydman","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2012.01.007_bib29","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1086\/341934","article-title":"National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997-2000","volume":"35","author":"Snydman","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2012.01.007_bib30","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/AAC.43.10.2417","article-title":"Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996","volume":"43","author":"Snydman","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mayocp.2012.01.007_bib31","series-title":"Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data","year":"2009"},{"key":"10.1016\/j.mayocp.2012.01.007_bib32","series-title":"Acceptable Anaerobe Control Strain Ranges for Minimal Inhibitory Concentration (MIC) Determination by Broth Microdilution and Agar Dilution Testing and Cumulative Antimicrobial Susceptibility Report for Bacteroides fragilis Group Bacteria","year":"2009"},{"key":"10.1016\/j.mayocp.2012.01.007_bib33","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria","year":"2007"},{"key":"10.1016\/j.mayocp.2012.01.007_bib34","series-title":"Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes","year":"2011"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","article-title":"Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy","volume":"19","author":"Brown-Elliott","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.1016\/j.mayocp.2012.01.007_bib36","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/JCM.01234-10","article-title":"Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Nocardia species","volume":"48","author":"Verroken","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.01.007_bib37","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/AAC.32.12.1776","article-title":"Antimicrobial susceptibility patterns of Nocardia asteroides","volume":"32","author":"Wallace","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.35.4.847-852.1997","article-title":"Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex","volume":"35","author":"Ambaye","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.01.007_bib39","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/657399","article-title":"Antimicrobial-resistant Nocardia isolates, United States, 1995-2004","volume":"51","author":"Udhe","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"RR-7","key":"10.1016\/j.mayocp.2012.01.007_bib40","first-page":"1","article-title":"Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis","volume":"42","year":"1993","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1128\/jcm.35.4.1041-1042.1997","article-title":"Turnaround time for mycobacterial cultures","volume":"35","author":"Styrt","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mayocp.2012.01.007_bib42","series-title":"Public Health Mycobacteriology: A Guide for the Level III Laboratory","author":"Kent","year":"1985"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/JCM.42.3.1109-1114.2004","article-title":"Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method","volume":"42","author":"Scarparo","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03256410","article-title":"Detecting drug-resistant tuberculosis: the importance of rapid testing","volume":"15","author":"Hoek","year":"2011","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS-IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mayocp.2012.01.007_bib46","series-title":"Essential Procedures in Clinical Microbiology","first-page":"105","article-title":"Antimicrobial susceptibility tests","author":"Hindler","year":"1997"},{"key":"10.1016\/j.mayocp.2012.01.007_bib47","series-title":"Clinical Microbiology Procedures Handbook","article-title":"\u03b2-Lactamase tests","author":"Leitch","year":"1992"},{"key":"10.1016\/j.mayocp.2012.01.007_bib48","series-title":"\u03b2-Lactamases","first-page":"291","article-title":"\u03b2-Lactamases of Staphylococcus aureus","author":"Dyke","year":"1979"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1469-0691.2008.01997.x","article-title":"Comparison of phenotypic methods for penicillinase detection in Staphylococcus aureus","volume":"14","author":"Kaase","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.mayocp.2012.01.007_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cll.2010.01.005","article-title":"Staphylococcus aureus: an old pathogen with new weapons","volume":"30","author":"Tang","year":"2010","journal-title":"Clin Lab Med"},{"issue":"5","key":"10.1016\/j.mayocp.2012.01.007_bib51","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JCM.00326-08","article-title":"Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopepetide-resistant Enterococcus species","volume":"46","author":"Malhotra-Kumar","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.mayocp.2012.01.007_bib52","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1128\/JCM.43.11.5536-5540.2005","article-title":"Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares","volume":"43","author":"Flayhart","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1469-0691.2009.02698.x","article-title":"Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs","volume":"15","author":"Struelens","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.mayocp.2012.01.007_bib54","first-page":"S53","article-title":"Conventional and molecular methods for the detection of methicillin-resistant Staphylococcus aureus","volume":"49","author":"Marlowe","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1309\/6EA3U9V8NCLLGKQN","article-title":"Real-time PCR can rapidly detect methicillin-susceptible and methicillin-resistant Staphylococcus aureus directly from positive blood culture bottles","volume":"124","author":"Paule","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.mayocp.2012.01.007_bib56","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/jcp.2008.055681","article-title":"The combined oxacillin resistance and coagulase (CORC) test for rapid identification and prediction of oxacillin resistance in Staphylococcus species directly from blood culture","volume":"61","author":"Carey","year":"2008","journal-title":"J Clin Pathol"},{"issue":"11","key":"10.1016\/j.mayocp.2012.01.007_bib57","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1128\/jcm.33.11.3008-3018.1995","article-title":"Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci","volume":"33","author":"Swenson","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.mayocp.2012.01.007_bib58","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/JCM.36.10.2996-3001.1998","article-title":"Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan Dried Overnight Gram-Positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci","volume":"36","author":"Chen","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib59","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/313949","article-title":"Aminoglycoside resistance in enterococci","volume":"31","author":"Chow","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/mdr.2009.0917","article-title":"Genetic diversity of enterococci harboring the high-level gentamicin resistance gene aac(6')-Ie-aph(2'')-Ia or aph(2'')-Ie in a Japanese hospital","volume":"15","author":"Watanabe","year":"2009","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.mayocp.2012.01.007_bib61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2180-7-112","article-title":"A nanoplex PCR assay for the rapid detection of vancomycin and bifunctional aminoglycoside resistance genes in Enterococcus species","volume":"7","author":"Yean","year":"2007","journal-title":"BMC Microbiol"},{"issue":"10","key":"10.1016\/j.mayocp.2012.01.007_bib62","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/j.ajic.2008.10.010","article-title":"The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients","volume":"36","author":"Salgado","year":"2008","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijantimicag.2007.08.026","article-title":"Vancomycin-resistant enterococci (VRE): transmission and control","volume":"31","author":"Tacconelli","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib64","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-resistant enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2012.01.007_bib65","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/491711","article-title":"Vancomycin resistance in gram positive-cocci","volume":"42","author":"Courvalin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2012.01.007_bib66","unstructured":"Gazin M, Lammens C, Goossens H, Malhotra-Kumar S. Evaluation of GeneOhm VanR and Xpert vanA\/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci [published online ahead of print June 12, 2011]. Eur J Clin Microbiol Infect Dis. doi 10.1007\/s10096-011-1306-y."},{"issue":"11","key":"10.1016\/j.mayocp.2012.01.007_bib67","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1128\/JCM.01522-10","article-title":"Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant enterococci in rectal swab specimens","volume":"48","author":"Stamper","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.mayocp.2012.01.007_bib68","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1309\/TWY5-04QE-9KV0-52MT","article-title":"Comparison of two commercially available selective media to screen for vancomycin-resistant enterococci","volume":"117","author":"Shigei","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diagmicrobio.2010.11.005","article-title":"Diagnostic accuracy of the Cepheid GeneXpert vanA\/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Enterococcus from perianal specimens","volume":"69","author":"Marner","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2012.01.007_bib70","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JCM.00326-08","article-title":"Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species","volume":"46","author":"Malhotra-Kumar","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib71","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1128\/JCM.00663-10","article-title":"Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations","volume":"48","author":"Bowling","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib72","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2012.01.007_bib73","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/AAC.00315-11","article-title":"Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009","volume":"55","author":"Richter","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mayocp.2012.01.007_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1469-0691.2007.01881.x","article-title":"Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-hemolytic streptococci of Lancefield groups A, B, C, and G in Seville, Spain","volume":"14","author":"Merino Diaz","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib75","first-page":"637","volume":"30","author":"Ji","year":"2010","journal-title":"Korean J Lab Med"},{"issue":"8","key":"10.1016\/j.mayocp.2012.01.007_bib76","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1508.081187","article-title":"Increase in pneumococcus macrolide resistance, United States","volume":"15","author":"Jenkins","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2012.01.007_bib77","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1128\/JCM.00960-11","article-title":"Evaluation of disk approximation and single-well broth tests for detection of inducible clindamycin resistance in Streptococcus pneumoniae","volume":"49","author":"Jorgensen","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.mayocp.2012.01.007_bib78","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1128\/AAC.46.11.3624-3626.2002","article-title":"Clinical strain of Pseudomonas aeruginosa carrying a blaTEM-21 gene located on a chromosomal interrupted TnA type transposon","volume":"46","author":"Dubois","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib80","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile \u03b2-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib81","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.01405-06","article-title":"First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing \u03b2-lactamase","volume":"51","author":"Villegas","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mayocp.2012.01.007_bib82","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2009"},{"issue":"8","key":"10.1016\/j.mayocp.2012.01.007_bib83","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/JCM.00015-07","article-title":"Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae","volume":"45","author":"Anderson","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib84","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1469-0691.2001.00204.x","article-title":"Modified Hodge and EDTA: disk synergy tests to screen metallo-beta-lactamase producing strains of Pseudomonas and Acinetobacter species","volume":"7","author":"Lee","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.mayocp.2012.01.007_bib85","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC \u03b2-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.mayocp.2012.01.007_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","article-title":"Plasmid-determined Amp-C type \u03b2-lactamases","volume":"46","author":"Philippon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.mayocp.2012.01.007_bib87","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/JCM.38.5.1791-1796.2000","article-title":"Occurrence and detection of AmpC \u03b2-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center","volume":"38","author":"Coudron","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.01.007_bib88","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1128\/JCM.42.5.2203-2206.2004","article-title":"Use of \u03b2-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC \u03b2-lactamases","volume":"42","author":"Black","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.mayocp.2012.01.007_bib89","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1128\/JCM.42.10.4799-4802.2004","article-title":"New method for laboratory detection of AmpC \u03b2-lactamases in Escherichia coli and Klebsiella pneumoniae","volume":"42","author":"Nasim","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.mayocp.2012.01.007_bib90","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/JCM.43.8.4168-4171.2005","article-title":"Evaluation of \u03b2-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC \u03b2-lactamases in well-characterized clinical strains of Klebsiella spp","volume":"43","author":"Black","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib91","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1128\/JCM.43.6.2551-2558.2005","article-title":"Practical methods using boronic acid compounds for identification of class C \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli","volume":"43","author":"Yagi","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.mayocp.2012.01.007_bib92","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/JCM.43.8.4163-4167.2005","article-title":"Inhibitor-based methods for detection of plasmid-mediated AmpC \u03b2-lactamases in Klebsiella spp. Escherichia coli, and Proteus mirabilis","volume":"43","author":"Coudron","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.mayocp.2012.01.007_bib93","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/AAC.00862-08","article-title":"Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis","volume":"53","author":"Tan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib94","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/JCM.01797-08","article-title":"Identification of plasmid-mediated AmpC \u03b2-lactamases in Escherichia coli, Klebsiella spp. and Proteus species can potentially improve reporting of cephalosporin susceptibility testing results","volume":"47","author":"Tenover","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9343(84)90662-4","article-title":"Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia","volume":"76","author":"Sculier","year":"1984","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2012.01.007_bib96","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinids\/8.5.803","article-title":"The serum bactericidal test","volume":"8","author":"Reller","year":"1986","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib97","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0272-2712(18)30726-1","article-title":"Antimicrobial susceptibility tests and their role in therapeutic drug monitoring","volume":"7","author":"DeGirolami","year":"1987","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.mayocp.2012.01.007_bib98","series-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents","year":"1999"},{"issue":"9","key":"10.1016\/j.mayocp.2012.01.007_bib99","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/archinte.1979.03630460058018","article-title":"Serious staphylococcal infections with strains tolerant to bactericidal antibiotics","volume":"139","author":"Denny","year":"1979","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib100","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/clinids\/7.3.368","article-title":"Antibiotic tolerance among clinical isolates of bacteria","volume":"7","author":"Handwerger","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.01.007_bib101","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.30.4.521","article-title":"Antibiotic tolerance among clinical isolates of bacteria","volume":"30","author":"Tuomanen","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib102","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.prrv.2007.04.006","article-title":"Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: \u2018the motion for.'","volume":"8","author":"Saiman","year":"2007","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib103","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.26.2.220","article-title":"Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and \u2013resistant Staphylococcus aureus","volume":"26","author":"Bayer","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib104","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1128\/AAC.40.3.677","article-title":"Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa","volume":"40","author":"Cappelletty","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.diagmicrobio.2008.11.002","article-title":"The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay","volume":"63","author":"Pankey","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mayocp.2012.01.007_bib106","series-title":"Methodology for the Serum Bactericidal Test","year":"1999"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib107","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000441-194906000-00002","article-title":"Effective penicillin therapy in subacute bacterial endocarditis and other chronic infections","volume":"217","author":"Schlichter","year":"1949","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib108","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0002-9343(85)90436-X","article-title":"Multicenter collaborative evaluation of a standardized bactericidal test as a prognostic indicator in infective endocarditis","volume":"78","author":"Weinstein","year":"1985","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib109","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0002-9343(87)90688-7","article-title":"Multicenter collaborative evaluation of a standardized bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis","volume":"83","author":"Weinstein","year":"1987","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","article-title":"The changing face of epidemiology of invasive fungal disease in Europe","volume":"52","author":"Lass-Fl\u00f6rl","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.mayocp.2012.01.007_bib111","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","year":"2008"},{"key":"10.1016\/j.mayocp.2012.01.007_bib112","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","year":"2008"},{"key":"10.1016\/j.mayocp.2012.01.007_bib113","series-title":"Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts","year":"2009"},{"key":"10.1016\/j.mayocp.2012.01.007_bib114","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi","year":"2008"},{"key":"10.1016\/j.mayocp.2012.01.007_bib115","series-title":"Method for Antifungal Disk Diffusion Susceptibility Testing of Nondermatophyte Filamentous Fungi","year":"2010"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib116","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, pharmacodynamics, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib117","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib118","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.mayocp.2012.01.007_bib119","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.diagmicrobio.2011.07.007","article-title":"Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method","volume":"71","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib120","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3109\/13693781003586943","article-title":"Evaluation of the E-test method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins","volume":"48","author":"Martos","year":"2010","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.mayocp.2012.01.007_bib121","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1128\/JCM.00493-08","article-title":"Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib122","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/JCM.00134-07","article-title":"Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin","volume":"45","author":"Espinel-Ingroff","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.01.007_bib123","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/JCM.02517-10","article-title":"Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp","volume":"49","author":"Peterson","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.mayocp.2012.01.007_bib124","first-page":"S39","article-title":"A critical appraisal of the role of the clinical microbiology laboratory in diagnosis of invasive fungal infections","volume":"49","author":"Klutts","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mayocp.2012.01.007_bib125","series-title":"Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas","year":"2011"},{"issue":"2","key":"10.1016\/j.mayocp.2012.01.007_bib126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1086\/653535","article-title":"High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China","volume":"51","author":"Cao","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.01.007_bib127","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3201\/eid1706.101558","article-title":"Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010","volume":"17","author":"Averbuch","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"9, suppl","key":"10.1016\/j.mayocp.2012.01.007_bib128","first-page":"S5","article-title":"Critical assessment of issues applicable to development of antimicrobial susceptibility testing breakpoints","volume":"49","author":"Jenkins","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612001978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612001978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:27:29Z","timestamp":1758418049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619612001978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0025619612001978"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.01.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Concepts in Laboratory Testing to Guide Antimicrobial Therapy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}